Table 3.
Comparison of patient’s demographic parameters between NGS (Group A) and aCGH (Group B) in Phase II study
| Parameters | NGS | aCGH | p |
|---|---|---|---|
| Total number of patients completed study | 83 | 81 | |
| Mean female age ± SD | 35.5 ± 3.3 | 35.2 ± 3.5 | 0.573 |
| Mean D3 FSH (mUI/mL) ± SD | 7.2 ± 1.6 | 7.1 ± 1.5 | 0.680 |
| Mean AMH (ng/mL) ± SD | 5.1 ± 2.1 | 4.6 ± 2.3 | 0.148 |
| Mean E2 (pg/mL) ± SD | 25.7 ± 3.2 | 26.3 ± 3.6 | 0.261 |
| Mean antral follicles ± SD | 12.3 ± 3.0 | 12.8 ± 2.8 | 0.272 |
| Mean sperm count (million/mL) ± SD | 35.4 ± 4.5 | 36.1 ± 4.2 | 0.305 |
| Mean sperm motility (%) ± SD | 49.6 ± 15.1 | 48.5 ± 14.7 | 0.637 |
There is no significant difference in any of the parameters between the two groups (p >0.05, by t test)
SD Standard deviation, NS No significant difference between the two groups, FSH Follicle stimulation hormone, AMH Anti-Müllerian hormone, E 2 Estradiol